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l Study rationale and methods
In recent years, signals from both formal and informal 
monitoring sources based in a number of European 
countries have been indicating increased cocaine 
production and availability: the opening of new online 
markets, reports of increased use, use of new technologies 
(cryptomarkets, social media and encrypted messaging 
platforms), and rising numbers of cocaine-related hospital 
admissions, and even deaths, in some countries.
To investigate these changes and developments in the 
supply and demand of one of Europe’s more established 
illicit drugs, a targeted ‘trendspotter’ study was initiated by 
the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) and carried out between March and 
June 2018. The primary aim of the study was to increase 
understanding of recent changes in the cocaine market in 
Europe. More specifically, it set out to explore levels of and 
patterns in powder cocaine and crack cocaine use; the 
market, including production, supply and product 
availability; drug-related harms and deaths; and the 
implications for law enforcement, health and social 
responses, and monitoring.
The study commenced with a phase of data collection and 
a literature review undertaken by a team drawn from 
various sectors within the EMCDDA, and culminated in an 
expert meeting in Lisbon on 21-22 June 2018. Fourteen 
experts attended the meeting, sharing their experiences 
and contributing to an in-depth analysis of the topic, 
providing insights from drug research and monitoring, 
wastewater analysis, law enforcement, and health 
perspectives.
The trendspotter study methodology incorporates a range 
of investigative approaches and data collection from 
multiple sources (EMCDDA, 2018d). This study included 
two web surveys among experts on the topic; a review of 
the international literature and available monitoring data; 
and, as part of the expert meeting, 14 expert presentations 
and findings from three facilitated working groups. The 
analysis was based on triangulation of these information 
sources, with a view to providing as complete and verified 
a picture as possible. The combination of routine and 
survey data with key informant reports and law 
enforcement intelligence provided a rich and in-depth view 
of a rapidly changing phenomenon. This report 
summarises the study findings and conclusions. Where 
results are literature-based, references are cited; 
otherwise, findings are based on EMCDDA monitoring and 
the qualitative sources described above. In this report, the 
term ‘cocaine’ refers to cocaine products in general (salt 
and base forms). Where it is possible to distinguish 
between the different products, the term ‘powder cocaine’ 
is used to refer to the hydrochloride salt form and the term 
‘crack cocaine’ (or simply ‘crack’ or ‘freebase’) is used to 
refer to the base form.
l Cocaine: a range of products
Cocaine is most commonly used in its hydrochloride salt 
form. Cocaine hydrochloride salt is generally prepared by 
extracting the crude coca paste from the coca leaf; this 
paste is then purified to the base form, which is then 
converted into a hydrochloride salt using hydrochloric acid 
(Casale and Klein, 1993). Cocaine hydrochloride usually 
appears as a white crystalline powder. This form of cocaine 
is generally snorted (intranasal route) but can also be 
dissolved in water and injected. The hydrochloride salt is 
not smokable, as it is destroyed at high temperatures, 
resulting in negligible to no psychoactive effects. Street 
names for cocaine hydrochloride include (but are not 
limited to) coke, blow, snow, flake, white, powder, dust, C 
and Charlie. The combination of cocaine hydrochloride and 
heroin, generally injected, is often referred to as 
a ‘speedball’.
Crack cocaine is obtained by dissolving cocaine 
hydrochloride in water; this solution is then made alkaline 
using ammonia or sodium bicarbonate. This mixture is 
then heated, producing a solid residue (Perrine, 1996). 
While practically insoluble in water, crack cocaine is 
smokable and vaporises at a temperature of 90 °C, much 
lower than the hydrochloride salt’s melting point of 190 °C. 
Crack cocaine can also be injected if a weak acid such as 
lemon juice is added to it to increase its solubility 
(Waninger et al., 2008). Examples of street names include 
base, rock(s), crack, moonrock, snow coke, gravel, etc. 
Smoking the mixture produces a crackling sound, which is 
the origin of the term ‘crack’.
The speed of onset of the effects of cocaine varies 
depending on the route of administration. The inhalation of 
vapours (crack only) achieves the fastest onset of effects, 
after approximately 3-5 seconds, followed by the 
intravenous and intranasal routes. The duration of effects 
is reported as approximately 5-15 minutes for inhalation of 
vapours, 20-60 minutes for the intravenous route and 
60-90 minutes for the intranasal route (Goldstein et al., 
2009).
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l  Cocaine markets: production and supply
l  Global market context
The quantity of cocaine seized worldwide in 2016 reached 
1 129 tonnes, a 23 % increase on the previous year and the 
highest level ever reported (UNODC, 2018). The main 
consumer markets for cocaine are North America and western 
and central Europe. North America (the United States and 
Canada) remains the world’s largest cocaine market, where 
more than one third (34 %) of all cocaine users reside. In 
2016, the United States was the main destination country for 
cocaine shipments intercepted in South America, the primary 
cocaine-producing region in the world. Between 2013 and 
2016, the quantity of cocaine seized in the United States rose 
by more than 40 %, and the annual prevalence of cocaine use 
among the general population in the United States increased 
during the same period (SAMHSA, 2017). The number of 
cocaine-related deaths in the United States more than 
doubled between 2013 and 2016, with the latest figures 
reporting more than 10 000 deaths, often related to cocaine 
used in combination with synthetic opioids.
Europe is the second largest market for cocaine, with an 
estimated retail market with an annual value worth 
a minimum of EUR 5.7 billion (EMCDDA, 2018b). However, 
findings from the recent World Drug Report (UNODC, 2018) 
reveal that most increases in the quantities of cocaine 
seized in 2016 took place outside these two main cocaine 
destination markets, confirming the ongoing spread of 
cocaine trafficking to emerging markets, which contributes 
to the proliferation of trafficking routes across the globe. 
Although relatively small compared with the amounts seized 
in North America and Europe, the quantity of cocaine seized 
in Asia tripled between 2015 and 2016, especially in south 
Asia, which saw a 10-fold increase. The quantity of cocaine 
seized in the Near and Middle East/south-west Asia 
doubled in 2016 compared with the previous year.
In South America, Central America and the Caribbean, the 
available data suggest that less than 1 % of the adult 
population had used cocaine in any form (except by 
chewing coca leaves) during the past 12 months (UNODC, 
2017). A recent trendspotter study covering 32 countries 
in these three regions revealed that in 18 countries 
a recent increase in the market availability of cocaine 
(powder and/or base) had been noted, while less than half 
of the countries involved in the study reported a recent 
change in powder cocaine use, and the available data 
suggest a possible downward trend in powder cocaine use 
in South America (EMCDDA and COPOLAD, 2018).
l  Trends in coca cultivation and cocaine production
Recent surges in cocaine availability across global drug 
markets reflect the significant developments in global 
cocaine manufacture, with recent data indicating record 
levels of production. In 2016, global coca bush cultivation 
was estimated to have increased for the third consecutive 
year, to reach 213 000 ha (UNODC, 2018), its highest level 
since a peak of 221 300 ha in 2000 (UNODC, 2004). This 
represents an increase of 36 % on 2015 and of 76 % on 
2013, when global coca cultivation was at its lowest level 
since 1990. The 2016 increase in the global coca acreage 
was due to increases in each of the three Andean producer 
countries (Bolivia, Colombia and Peru), albeit of different 
magnitudes, with the largest increase taking place in 
Colombia. Coca cultivation increased by an estimated 
14 % in Bolivia (to 23 100 ha) and 9 % in Peru (to 
43 900 ha) between 2015 and 2016. More significantly, 
the coca acreage in Colombia increased by 52 %, from 
96 000 ha in 2015 to 146 000 ha in 2016. As a result, 
Colombia accounted for 68 % of estimated global coca 
cultivation in 2016, Peru for 21 % and Bolivia for about 
11 % (UNODC, 2018).
Multiple factors explain the increases in coca production in 
these countries. In the case of Colombia, the main 
explanations appear to be the negotiations for a peace 
agreement with the Revolutionary Armed Forces of 
Colombia (FARC), the suspension of eradication by means 
of aerial spraying of herbicides on coca crops and 
a reduction in alternative development programmes 
(UNODC, 2018). The increase in coca cultivation has 
resulted in an increase in total cocaine production, which 
may have reached 1 410 tonnes in 2016, an all-time high. 
Again, Colombia is estimated to be the largest cocaine 
producer and the country where the largest increase in 
production has taken place, resulting in an estimated 
866 tonnes of cocaine being produced in 2016 (3 times 
more than in 2013 and 34 % more than in 2015). Cocaine 
production has also increased in Bolivia and Peru, but not 
as dramatically as in Colombia (UNODC, 2018).
However, larger harvests of coca leaves are probably not 
the only explanation for the dramatic increase in estimated 
global cocaine production. There is also some evidence of 
increased sophistication in cocaine manufacturing 
methods, resulting, for instance, in streamlined 
hydrochloride production processes using limited amounts 
of chemicals, and the recycling of chemicals for use in 
multiple production runs. Another trend observed recently, 
which is probably linked to the latter, is the processing of 
larger batches of base cocaine into powder cocaine, when 
previously this was done one kilogram at a time (Mallette 
et al., 2018).
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Finally, there is some limited information available 
suggesting that the last stage of the cocaine production 
process, namely converting base to hydrochloride, may be 
being carried out in Europe. This may mean that cocaine is 
being exported to Europe in base form, but evidence 
documenting this is lacking. Alternatively, the base-to-
hydrochloride laboratories detected in Europe may be 
associated with the practice of importing cocaine hidden 
in carrier materials such as plastic. The cocaine in such 
cases is often retrieved in the form of base in secondary 
extraction facilities and then needs to be transformed into 
hydrochloride before being sold. Although it is known that 
using carrier materials to hide cocaine for importation into 
Europe is one of the methods used by traffickers, it seems 
that few secondary extraction laboratories have been 
dismantled in Europe, with only five countries reporting ten 
facilities since 2014 via the ad hoc European Reporting on 
Illicit Cocaine Extraction-Conversion Sites tool jointly 
developed by the EMCDDA and Europol. It is also possible, 
however, that more secondary extraction facilities have 
been found but have remained unreported.
l  Trafficking to Europe
Around 98 000 seizures of cocaine were reported in the 
European Union in 2016, amounting to 70.9 tonnes. 
Compared with the previous year, there was a small 
increase in the quantity of cocaine seized in 2016, and 
a more marked increase in the number of seizures. 
Although the increase was small in terms of the overall 
quantity of cocaine seized, significant increases were 
reported in countries in south-eastern and Baltic regions of 
the European Union. Between 2014 and 2016, Romania 
reported a 70-fold increase in the quantity of cocaine 
seized (2.3 tonnes in 2016), Poland reported a 15-fold 
increase (0.4 tonnes in 2016), Bulgaria, Cyprus, Latvia and 
Malta reported a four- to five-fold increase, and Turkey 
reported a more than two-fold increase in the amount 
seized during this period.
Western EU countries remain, however, the primary 
destination countries for wholesale cocaine trafficking. 
With seizures of around 30 tonnes of cocaine, or 43 % of 
the estimated EU total in 2016, Belgium displaced Spain 
(15.6 tonnes) as the country reporting the highest annual 
seizures of the drug. More recently, France reported 
17.5 tonnes of cocaine seized in 2017.
Regarding the record seizures in Belgium, more recent 
data are available from the Port of Antwerp: 41 tonnes 
were seized in 2017, and by the end of the first half of 
2018 cocaine seizures at the port had already exceeded 
21 tonnes. Information on seizures outside the European 
Union show that, on top of these record numbers, 
36 tonnes of cocaine in consignments having Antwerp as 
their final destination were intercepted in transit ports in 
Latin America in 2016. The following year, this figure rose 
to 45 tonnes, and 16 tonnes were seized during the first 
half of 2018. There are multiple reasons why the Port of 
Antwerp is used by organised crime groups for cocaine 
importation in Europe: it is physically a very open harbour 
area and is located within the city of Antwerp, facilitating 
rapid dispatch goods. The proximity of the Netherlands, 
which is known to be a central hub for organised crime 
groups involved in drug supply, is also a contributing factor. 
Antwerp is also one of the largest fruit handlers in Europe, 
with direct cargo lines scheduled weekly from Colombia, 
Ecuador, Guatemala and Panama. However, Antwerp is not 
the only port showing increased levels of cocaine 
importation into Europe. The container ports of Algeciras in 
Spain, Le Havre in France and Hamburg in Germany have 
all recorded large bulk seizures of cocaine.
l  Organised crime groups involved in the supply of cocaine
The increased influx of cocaine into Europe appears to 
have been facilitated by the involvement of a greater 
number of organised crime groups (OCGs). While the 
established Italian OCGs (the ’Ndrangheta and the 
Camorra) still hold a firm position in the international 
cocaine trafficking business, new players have emerged in 
recent years. The Italian OCGs were already known to have 
established their own trafficking connections directly in 
source countries in South America (McDermott, 2018). 
However, other established or emerging European OCGs 
that previously acquired their cocaine from the Italian 
OCGs have recently set up their own trafficking lines. They 
now procure cocaine for their national markets directly 
from source countries, which affects wholesale cocaine 
prices by removing an intermediate actor. Europol 
intelligence suggests that some British, Dutch, Irish, Italian 
and Spanish crime groups have developed into important 
brokers in the cocaine trade in this way.
Another important development is the increasing use of 
national overseas territories as transit points in order to 
benefit from their inclusion in the European single market 
and European customs territory and their geographical 
location close to source countries such as Colombia and 
Venezuela. For example, French OCGs make increasing 
use of connections through French Guiana and the French 
Antilles to smuggle bulk loads back to mainland France. 
Intelligence also suggests that Surinamese OCGs 
increasingly make use of a ‘French’ route via Cayenne and 
Orly airport in Paris to traffic cocaine into Europe, in order 
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to avoid more closely monitored routes between the 
capital of Suriname, Paramaribo, and the Dutch airport of 
Schiphol. Between 2016 and 2017, the number of drug 
couriers arrested at Orly airport in Paris increased from 
144 to 264. However, it is believed that between 3 500 and 
4 000 drug couriers manage to pass undetected yearly, 
carrying about 3-4 tonnes of cocaine into France. These 
drug couriers are mainly women, nationals from the 
poorest areas in overseas national territories and recruited 
on the basis of payments of between EUR 5 000 and 
EUR 6 000 per kilogram of cocaine they smuggle into 
Europe.
In addition, members of the so-called Balkan cartel have 
become more visible in South America in recent years. The 
Balkan OCGs have developed into modern and dynamic 
criminal networks and are held responsible for the 
transportation, financing and distribution of large amounts 
of cocaine shipped from South America into Europe. Their 
ability to access cocaine close to or directly from the 
source, combined with their presence in major European 
ports, results in their ability to control the end-to-end 
supply of cocaine. Similarly, Moroccan OCGs are now in 
the process of becoming an important player in the 
cocaine trade (Colman, 2018). They are known to be 
present mostly in the Netherlands and Belgium but also in 
France and Spain, as these OCGs make use of their 
established cannabis resin trafficking routes between 
western Europe and their country of origin. Finally, 
a significant presence of Colombian OCGs in Spain has 
been reported, as has close cooperation between 
Colombian OCGs and Spanish OCGs. Colombians in 
Europe are presumably performing a supervisory role in 
the cocaine trade between their country of origin and 
European markets, but they may also be exporting their 
expertise in processing cocaine products in secondary 
extraction laboratories to mainland Europe.
The fragmentation of the cocaine trade in Europe appears 
to have resulted in increased competition among OCGs for 
national and cross-border territories in cocaine supply and 
retail. One of the consequences has been an increase in 
violence and drug-related homicides in a number of 
European countries, such as, Belgium, Italy, the 
Netherlands and the United Kingdom. Recent media 
reports have highlighted an escalation in the number of 
homicides and kidnappings among criminal groups linked 
to the cocaine trade in these countries.
l The cocaine trade in online drug markets
Another potential form of fragmentation of the market can 
be seen in the use of new and more sophisticated 
technologies that allow an increasing number of actors to 
operate within more horizontal networks to deliver low-
volume direct-to-consumer cocaine sales via the darknet 
and encrypted communication applications. Although the 
extent to which they are replacing traditional retail supply is 
not yet clear, these new sales methods have the potential 
to considerably alter the nature of the cocaine trade.
Cocaine is among the drugs that generate the highest 
revenues for dealers operating in online and anonymised 
darknet markets. These cryptomarkets exist on the deep 
web, an area of the internet that has been intentionally 
hidden and is inaccessible through standard web 
browsers. A recent study revealed that on the AlphaBay 
marketplace, one of the leading cryptomarkets until it was 
taken down in 2017 (EMCDDA and Europol, 2017), 
cocaine was the drug that generated the third largest sales 
volume between 2015 and 2017 and also the third highest 
revenue, with total sales estimated at EUR 5.81 million in 
the United Kingdom, EUR 2.65 million in the Netherlands 
and EUR 1.55 million in Germany. Most cocaine-related 
transactions on AlphaBay occurred at the retail level, with 
71 354 transactions made during that same period, which 
accounted for the greatest proportion of all revenue (more 
than EUR 8 million) (Christin, 2017). Cocaine remains one 
of the most expensive commonly used drugs sold in 
European cryptomarkets, with prices per gram varying 
according to their geographical location and ranging from 
EUR 72 in Sweden, to EUR 85 in Italy and EUR 145 in 
Finland (Janetos and Tilly, 2017). While these prices 
appear to be higher than retail prices for cocaine at street 
level, the attraction of cryptomarkets includes both a sense 
of security in terms of evading law enforcement and also 
a perceived higher level of quality assurance through the 
rating systems applied to drug transactions with particular 
vendors; for these, buyers are prepared to pay a premium.
A recent study compared the darknet trading geography of 
cannabis, opioids and cocaine across four of the largest 
cryptomarkets with the global prevalence levels of use of 
those drugs (Dittus et al., 2018). The results showed that 
cocaine vendors were primarily located in a small number of 
highly active consumer countries, mostly in the United 
States and Europe, rather than in producer countries 
(Figure 1). This reinforces the findings on transaction size on 
AlphaBay described above, indicating that darknet vendors 
primarily inhabit the role of local retailers rather than 
removing or replacing higher levels of the supply chain. 
Darknet vendors probably still rely on some of the same 
producers and traffickers involved in the conventional 
cocaine trade. However, it appears that cryptomarkets 
reconfigure the ‘last mile’ of the cocaine supply chain and 
provide a novel form of retail distribution in certain 
consumer countries (see, for example, Demant et al., 2018).
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l  New methods in the supply of cocaine to consumers
Innovative methods of supplying cocaine to consumers 
have emerged across Europe. It is reported that call 
centres are operating that are dedicated to distributing 
cocaine via couriers in some parts of Belgium (De Ruyver 
et al., 2018). The call centres themselves, however, are 
physically located in western Balkan countries and Spain. 
Belgian consumers order a consignment via a central 
telephone number and then couriers operating in the 
national territory from which the order was made deliver 
the order rapidly to the location specified. These couriers 
appear to be very difficult to investigate or map, as there is 
a high turnover of undocumented couriers travelling to 
Belgium for a short period then returning, for example, to 
Albania. Reports show that, during these short periods, 
a courier can sell up to 1 kg of cocaine per week on 
average. A similar phenomenon has been reported in the 
greater Paris area, where home deliveries of cocaine are 
organised through similar call centres (Cadet-Taïrou et al., 
2017). In the United Kingdom, ‘county lines’ crime relates 
to the supply of drugs, primarily crack cocaine and heroin, 
from cities to market towns, coastal areas and rural 
locations couriered by young people; drugs are ordered 
using a branded mobile phone line. The most recent 
assessment of county lines crime in the United Kingdom 
suggests that there were more than 1 000 lines in 
operation, with links to increasing levels of serious 
violence. Communication among vendors, ‘runners’, or 
couriers, and buyers is facilitated by the use of semi-
private encrypted communication applications such as 
WhatsApp and Telegram, which makes it difficult for law 
enforcement to monitor such communication. Open public 
social media applications such as Instagram, Twitter and 
Facebook are used to promote time-limited offers to 
a wider, not targeted public. Emojis (e.g. snowflakes for 
powder cocaine), synonyms like ‘snow’, and videos and 
pictures of cocaine are used to promote and convey 
information about special trade offers (Figure 2). Research 
projects and media releases show that such public social 
media platforms and semi-private encrypted 
communication tools are commonly used across Europe 
for mid-level and retail cocaine trafficking, with reports of 
their use coming from the United Kingdom, Denmark, 
Finland, Germany, Italy, Norway, Spain and Sweden.
l  Purity increases and stable prices
Overall, indexed trends suggest an increase in cocaine 
purity between 2010 and 2016, with cocaine purity in 
FIGURE 1
Countries of origin of cocaine vendors on the darknet and number of trades based on buyer reviews
0-19 20-199             200-1999            2000-200 000
Buyer reviews
Source: adapted from Dittus et al. (2018) (https://arxiv.org/pdf/1712.10068.pdf). Copyright 2018 IW3C2 (International World Wide Web Conference 
Committee), published under Creative Commons CC BY 4.0 License.
FIGURE 2
Facebook post openly advertising powder cocaine sale
9Results from an EMCDDA trendspotter study I December 2018
Europe at the highest level seen in the past decade 
(EMCDDA, 2018b). When analysing cocaine purity trends 
between 2014 and 2016, increases can be seen in all the 
countries where data are available for both years, except 
Czechia and Portugal (Figure 3). Two clusters of countries 
emerge when looking at the changes in purity levels: one 
cluster is composed of countries where increases occurred 
in national average purity levels that were already above 
EU average levels back in 2014, and the other cluster of 
countries is made up those where increases occurred in 
national markets with relatively average purity levels 
(between 30 % and 50 % in 2014). In both clusters, some 
countries showed particularly marked increases compared 
with the baseline year, such as Greece, France and 
Slovenia in the first cluster of countries, and Denmark, the 
United Kingdom and Hungary in the second cluster of 
countries. It is also worth noting the increases in east 
European countries such as Latvia, Bulgaria, Lithuania and 
Romania, although average purity levels did not reach 
those observed in many major western European 
countries. The reported retail price of cocaine varies 
considerably among countries in Europe, ranging from 
EUR 44 (Portugal) to EUR 104 (Bulgaria) per gram, with an 
interquartile range of EUR 51-73 in 2016 (or the most 
recent year for which data are available) (EMCDDA, 
2018b). The indexed trend in the price per gram of cocaine 
in Europe between 2006 and 2016 shows a slight 
decrease over that period and a relatively stable trend in 
the past 2 years.
l  Adulteration
Cutting drugs with cheaper materials is usually undertaken 
to increase profit along the distribution chain but may also 
enhance or modify the effects of the drug and may cause 
additional adverse health consequences for the user. 
Among all illicit substances, powder cocaine appears to be 
the most adulterated: purity is lowest at street-level retail, 
samples contain on average three other compounds and, 
in one study, over 20 different substances were reported to 
be used as adulterants (Broséus et al., 2015; Villar Núñez 
et al., 2018). In addition to inert diluents such as sugars, 
talc, plaster and starch, pharmacologically active 
adulterants are often found in both powder cocaine and 
crack cocaine, including various local anaesthetics, 
FIGURE 3
Changes between 2014 and 2016 in percentage purity of cocaine hydrochloride
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analgesics, other licit and illicit stimulants, nootropic 
agents and anti-allergy drugs (Kudlacek et al., 2017).
The veterinary anthelmintic levamisole has been the most 
common adulterant of cocaine products over the past 
decade, followed by the analgesic phenacetin; both were 
identified by forensic laboratories and drug checking 
services in 40-70 % of cocaine samples analysed in recent 
European studies (Broséus et al., 2015; Brunt et al., 2017; 
Villar Núñez et al., 2018). In addition, levamisole appeared 
in used syringes in France, and in Switzerland, where 
phenacetin was also tested for and detected (Lefrançois et 
al., 2017; Néfau et al., 2015).
Levamisole is used as a cutting agent primarily because of its 
large-scale availability from the veterinary medicine market, 
and its similar colour and melting point to those of cocaine 
(its free base melts before crack cocaine, leaving no traces in 
the pipe); it is cheap, heavier than cocaine and gives 
a specific cocaine-like sheen to the drug, allowing for further 
adulteration down the retail chain (Brunt et al., 2017b). 
Levamisole has also been described as an effect enhancer; 
although its own neuropharmacological mechanism may be 
synergistic with that of cocaine, the main effect is probably 
related to aminorex. Aminorex is a metabolite of levamisole 
and has amphetamine-like pharmacological properties. It has 
a longer half-life than cocaine and may prolong the perceived 
stimulating effect of the drug (Solomon and Hayes, 2017). 
This would explain why some clients of drug  checking 
services actively seek levamisole-adulterated powder 
cocaine, and why, according to experts in our study, some 
powder cocaine and crack cocaine users consider 
unadulterated cocaine to be of lower quality.
The most recent data from drug checking services across 
Europe show an overall decline in cocaine adulteration and 
a growing proportion of samples diluted only by inert 
compounds. The resulting higher purity of cocaine may in 
part be an indication of a disrupted supply of cutting 
agents, possibly linked to attempts to control the trade in 
these substances in some EU countries, such as the 
Serious Crime Act 2015 in the United Kingdom, which 
allows the seizure and confiscation of cutting agents 
(ACMD, 2015).
l  Cocaine use
l  Prevalence of and patterns in cocaine use
In recent years, cocaine has been part of a dynamic and 
interchangeable stimulant market characterised by an 
increasing choice of high-purity stimulant drugs (potent 
ecstasy tablets, amphetamines, a multiplicity of cheap 
synthetic cathinones and other new psychoactive 
substances). The recent increase in the availability of 
higher purity cocaine on Europe’s drug markets appears to 
be repositioning cocaine as the stimulant drug of choice.
Much information on cocaine use comes from general 
population and targeted surveys, and most surveys across 
Europe have traditionally collected data on cocaine as 
a generic category, rather than collecting data specifically 
on powder cocaine and crack cocaine. The most recent 
EU-level estimate suggests that around 2.3 million young 
adults (aged 15-34 years) used cocaine in the last year 
(1.9 % of this age group), with national estimates ranging 
from 0.2 % to 4.0 %. The countries with the highest 
prevalence of cocaine use in Europe include Denmark, 
Ireland, the Netherlands, Spain and the United Kingdom, 
with prevalence estimates of 2.5 % or more. Cocaine is the 
predominant stimulant used in this young adult group 
(ahead of MDMA and amphetamines) in a number of 
countries, mainly in southern and western Europe.
These geographical patterns in cocaine consumption are 
confirmed by analyses of wastewater data that have found 
FIGURE 4
Cocaine residues in wastewater in selected European 
cities in 2017
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a week in 2017.
Source: Sewage Analysis Core Group Europe (SCORE).
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the highest levels of cocaine metabolites in cities in 
Belgium, Spain, the Netherlands and the United Kingdom, 
and the lowest concentrations in east European cities 
(EMCDDA, 2018b) (Figure 4). In most countries with 
multiple study locations, levels of cocaine metabolites in 
wastewater were higher in large cities than in smaller 
towns or cities. In addition to identifying geographical 
patterns, wastewater analysis can detect fluctuations in 
patterns of illicit drug use over a week. More than three 
quarters of cities showed higher levels of cocaine 
metabolites in wastewater at the weekend than on 
weekdays. This finding points to predominantly 
recreational use of cocaine in these cities. This conclusion 
is confirmed by cocaine hospital emergency presentations, 
with a similar pattern of increased emergency 
presentations for powder cocaine at weekends but an even 
distribution of crack cocaine-related emergency 
presentations throughout the week (see the ‘Harms and 
deaths’ section below).
l  Recent trends in cocaine use
Recent trends in cocaine use across several indicators do 
not seem to uniformly reflect the increased availability and 
scale of supply of the drug at European level. Thus, 
although the decreases in last year use of cocaine 
reported for several years in a number of general 
population surveys seem to have ceased, the general 
picture now suggests stable levels of use. Of the countries 
that have produced surveys since 2015, only 3 reported 
higher estimates while 14 countries reported a stable 
trend and 1 reported a lower estimate than in the previous 
comparable survey.
In contrast, analyses of wastewater reveal an increase in 
cocaine residues in 26 of the 32 cities for which data were 
available for 2015 and 2017, following a relatively stable 
period between 2011 and 2015 in most cities (Figure 5). 
While these data clearly indicate an increasing trend in 
residues during 2015-2017, questions remain about what 
is driving the increase in cocaine metabolites. While it may 
indicate that more people are consuming cocaine, it may 
mean that there is greater use of cocaine by the same 
people. Alternatively, it may simply reflect the increased 
purity of cocaine in Europe, leading to increased 
metabolite detection in wastewater. This increase could 
also be explained by a combination of these three causes. 
Similarly, data from an ad hoc survey for the purpose of the 
present study among several European drug checking 
services identified an increase in the number of powder 
cocaine samples being submitted for testing in the past 
2 years in recreational settings and an increase in purity.
FIGURE 5
Aggregated trends in cocaine residues in wastewater in 
10 European cities, 2011 to 2017
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NB: trends in mean daily amounts of benzoylecgonine in milligrams per 
1 000 head of population in Antwerp Zuid (BE), Barcelona, Castellon and 
Santiago (ES), Paris Seine Centre (FR), Zagreb (HR), Milan (IT), Eindhoven 
and Utrecht (NL), and Oslo (NO). These 10 cities were selected owing to the 
availability of annual data for 2011-2017.
Furthermore, the trend in the number of people seeking 
treatment for powder cocaine-related problems across 
Europe has also shown an increase in recent years 
(Figure 6). The overall number of people entering 
treatment for the first time in their lives for powder cocaine 
use has increased by almost a quarter (23 %, around 4 700 
clients) since 2014. Fourteen countries reported increases 
in the number of first-time treatment entrants for primary 
powder cocaine use between 2014 and 2016, with 
increases of more than 30 % in Greece, France, Italy, 
Hungary and the United Kingdom. Increases in the number 
of first-time treatment entrants for crack cocaine between 
2014 and 2016 were reported in Belgium, Ireland, France, 
Italy and the United Kingdom.  Overall, the latest European 
data reveal a lag of about 12 years between first powder 
cocaine use, on average at the age of 22, and first 
treatment for cocaine-related problems, on average at the 
age of 34. This long period from initiation to development 
of problems and seeking treatment raises a number of 
questions regarding the recent increases in demand for 
treatment for cocaine-related problems. For example, it is 
unclear if the cocaine-related problems that encouraged 
people to seek treatment between 2014 and 2016 
intensified with the current increase in high-purity cocaine 
available on national markets or if these problems 
developed among a cohort of cocaine users who started 
using cocaine during the last wave of high availability of 
cocaine in Europe in 2006.
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FIGURE 6
Trend in the number of first-time treatment entrants for 
primary cocaine use between 2014 and 2016 in 28 
European countries
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l  Powder cocaine and crack cocaine: different user groups
For research and monitoring purposes, people who use 
cocaine have been categorised in different ways, according 
to the setting, the product used or the motivation for using. 
It should be noted that the terminology used in the 
literature and in collecting the current data is sometimes 
used interchangeably to refer to crack cocaine and powder 
cocaine, and the size of certain user groups may be 
underestimated as a result. Such underestimation may 
also may be because of stigma (people not perceiving 
themselves as crack users or refusing to admit its use), 
a misunderstanding of the products by the users, 
researchers or professionals, or the inadequacy of the 
monitoring instruments. For example, the latest data on 
new clients entering treatment in Europe show that 18 % 
reported smoking/inhaling as the main route of 
administration for cocaine hydrochloride. Since cocaine 
hydrochloride produces negligible to no stimulant effects 
when smoked, this may be due to clients reporting their 
crack use as cocaine use or to a lack of understanding of 
the difference between inhaling and snorting. In any case, 
these limitations may lead to underestimation of various 
using populations and may bias any attempt to 
characterise different groups.
l  Recreational/occasional users and nightlife settings
Unlike other recreationally used drugs, which are often 
associated with specific subcultures and settings, cocaine 
has a more universal profile, and its various forms and 
routes of administration allow for a certain tailoring of its 
effects. A French study on the drug-using careers of people 
who used cocaine found that initiation was often 
motivated by curiosity and the perceived high status of the 
drug, which ‘one does not simply refuse’. Users often seek 
energy, endurance, a feeling of ease and friendliness in 
social contacts, and sexual stimulation; the duration and 
intensity of the effects were considered by users to be 
easier to control than those of other drugs (Reynaud-
Maurupt et al., 2011).
Experts involved in this study reported that in European 
party settings, powder cocaine is often combined with 
other drugs, and the typical combinations include ecstasy/
MDMA and new psychoactive substances. Alcohol is the 
most common substance used in combination with 
cocaine; users report being able to consume more alcohol 
while maintaining a relatively high level of perceived 
sobriety, which may represent an important motivation to 
consume for some but can lead to the consumption of 
extreme quantities of alcohol. This can have severe 
harmful consequences for some, owing to the production 
of a toxic molecule, cocaethylene, in the body (see the 
‘Harms and deaths’ section below). The temporal order of 
use of alcohol and cocaine seems to play an important role 
for users, as alcohol ingested after cocaine helps to soothe 
anxiety and other unpleasant feelings associated with the 
diminishing effects of the stimulant drug (Pakula et al., 
2009).
These characteristics of cocaine, perceived as 
a permissive, functional and easily controlled drug that 
enhances social interactions and combines easily with 
alcohol, make it appealing in a wide range of nightlife 
settings, such as pubs, bars, concert venues and private 
parties. Trendspotter experts reporting on nightlife settings 
described the increasing acceptability and normalisation 
of use of powder cocaine across diverse social groups, 
which are manifested in greater overtness and visibility of 
use.
Occasional users often do not pay for cocaine, which is 
offered to them for free by friends and acquaintances, 
especially in party settings (Reynaud-Maurupt et al., 2011). 
This finding is confirmed by the 2017-2018 European Web 
Survey on Drugs: getting cocaine for free from friends was 
the most common source mentioned, by between 59 % 
and 67 % of respondents, in Austria, Latvia and Poland. 
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Only in Belgium had fewer respondents got cocaine for 
free than had bought it from a dealer (44 % compared with 
55 %). Purchasing their own cocaine from a dealer 
represents for some recreational users a step towards 
more serious engagement in cocaine use. Experts in this 
study reported that, with cocaine having recently become 
more affordable, drug-using partygoers have tended to 
switch from cheaper, ‘second-class’ stimulants, such as 
speed (amphetamines) or synthetic cathinones, to 
cocaine. It was also reported that, with the recent 
economic growth in some Baltic countries, cocaine has 
now entered the range of products offered by retail dealers, 
alongside cannabis and amphetamines, in these countries.
l  Socially integrated regular users
A subset of recreational cocaine users develops a more 
regular pattern of use, when the socially enhancing effects 
or increased efficiency are sought beyond party settings 
and cocaine is used in demanding work environments or 
as part of other daily routines. Cocaine is also used among 
this group for its enhancing effects on sexual behaviours. 
A need to cope with tiredness after weekend activities, 
exhaustion and also the availability of the drug were 
described as contributing to regular cocaine use 
(Reynaud-Maurupt et al., 2011). This group of cocaine 
users is characterised by attempts to control the habit 
while slowly progressing towards dependence and may 
remain relatively hidden from social services. Treatment 
experts in this study reported that help is generally sought 
only after the user has developed severe health and social 
problems, which appear with more frequent or heavy use. 
This group most likely constitutes the large majority of 
those entering treatment for powder cocaine-related 
problems in Europe. About 25 000 individuals sought 
treatment for powder cocaine problems for the first time in 
their lives in 2016. Alcohol is the most commonly reported 
secondary problem substance among this group, and one 
fifth of those entering first-time treatment for cocaine use 
report using cocaine on a daily basis. The male to female 
ratio among this group is 6:1.
l  Users of crack cocaine
Smoking crack cocaine radically transforms the effects of 
the drug; the rapidness and intensity of onset lead to 
a sensation or ‘rush’ that is rarely described by users of 
powder cocaine (Reynaud-Maurupt et al., 2011). Crack 
users describe feelings of detachment, pleasure and 
disconnection from problems not dissimilar to those 
associated with heroin. The initial pleasure is short and 
followed by a sharp withdrawal involving anxiety, feelings 
of guilt and a strong craving to use again, often leading to 
compulsive patterns of use. Experts in the field reported 
that, unlike in the case of heroin, crack cocaine 
dependence does not necessarily involve daily use; crack 
is often used in binges that may last for days until physical 
or economic exhaustion.
In Europe, crack cocaine has historically seemed to be 
limited to some cities in the west (in Spain, France, 
Germany, the Netherlands and the United Kingdom), 
although the most recent reports suggest diffusion from 
capitals such as Paris and Dublin to smaller, regional 
cities. National experts reported that users of crack 
cocaine are often marginalised, either street homeless 
polydrug users (Ireland), migrants from eastern Europe 
who switch from amphetamines to crack (France), 
migrants who belong to ethnic minority groups (France 
and Denmark) or nationals who are long-term users of 
crack cocaine and other drugs (Frankfurt). In Paris, the 
open drug scene associated with crack cocaine appears to 
extend from the usual confined drug scenes to more public 
areas and is linked to noticeable street violence. A recent 
qualitative study in Frankfurt indicated that users in opioid 
substitution treatment who miss the high associated with 
heroin turn to crack as a replacement (Werse et al., 2018). 
It was also reported that heroin users whose veins are 
damaged from injecting may begin smoking crack cocaine. 
Recent EMCDDA data show that 40 % of all crack users 
seeking treatment report heroin as their secondary drug 
(EMCDDA, 2018c). Furthermore, every third person 
entering treatment for a crack cocaine-related problem in 
Europe is a woman. Crack cocaine is reported to contribute 
to a vicious circle of crack cocaine use and sex work 
among female users, with prostitution functioning as 
a means to fund dependence and crack cocaine use acting 
as a ‘numbing’ way to cope with sex work (Daniulaityte and 
Carlson, 2011).
In the context of this study, experts reported that in most 
European countries where crack cocaine use is observed, 
crack cocaine has a different distribution chain from 
powder cocaine and users purchase crack cocaine or 
‘rocks’ as a finished product to be consumed. An 
interesting phenomenon is, however, observed in France. 
Although chemically identical, freebase and crack in 
France represent two separate markets and have different 
user groups, based primarily on a belief that these are two 
different substances. Crack cocaine, usually associated 
with the negative images of street dealers and 
marginalised drug users (‘crackheads’), is believed to be 
a residue from the production of cocaine hydrochloride 
and considered a low-class drug. Conversely, freebasing 
powder cocaine with baking soda or ammonia is believed 
to purify the substance, and cocaine is traditionally 
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consumed in this way in private or alternative party 
settings by recreational drug users (Gandilhon et al., 
2013). The most recent developments suggest 
a convergence of the two scenes. Less-experienced 
freebase users developing a severe dependence are 
merging with the established marginalised group in the 
existing crack scene in order to consume cheaper, ready-
to-use products.
l  People who inject powder cocaine and crack cocaine: a worrying increase
Like any other soluble drug, cocaine can be injected and 
the transition to injecting often marks progression to more 
severe levels of dependence and harms (Dunn and 
Laranjeira, 1999). Cocaine has been identified in disposed 
syringes in France and Switzerland, either alone or in 
combination with other substances (Lefrançois et al., 
2017; Néfau et al., 2015). Cocaine and heroin are known to 
be injected together to intensify the desired effects and to 
supress the unpleasant effects of both drugs. Data from 
drug consumption rooms in France, Germany, 
Luxembourg, Spain and Switzerland indicate an increase 
in the number of injection events over the past 3 years 
involving powder cocaine alone or in combination with 
heroin, while a decrease in the number of heroin injection 
events in these consumption rooms is reported. Some also 
report an increasing trend in crack cocaine injecting as 
a cheaper alternative to traditional speedball preparations: 
instead of using powder cocaine, crack cocaine is used in 
combination with morphine sulphate, methadone or 
buprenorphine. This study also identified other 
combinations, including crack cocaine with heroin and 
benzodiazepines. Of all clients entering treatment for 
cocaine-related problems in Europe, 5 % report injecting as 
the main route of administration of powder cocaine and 
3 % report injecting as the main route of administration of 
crack cocaine.
l Harms and deaths
l  Cocaine-related harms
Reports of health problems related to the use of powder 
cocaine and crack cocaine appear to be relatively common. 
It is likely that the risks are greater when cocaine use is 
associated with polysubstance use and with the use of 
high-purity products. As mentioned earlier, cocaine is 
commonly consumed with high quantities of alcohol. 
However, if ethanol is present during the metabolism of 
cocaine, a portion of the cocaine undergoes a chemical 
reaction with ethanol that results in the production of 
cocaethylene. In most users, cocaethylene produces 
euphoria and has a longer duration of action than cocaine. 
Some studies suggest that it may be more cardiotoxic than 
cocaine and may be 18 to 25 times more likely than 
cocaine alone to result in immediate death (Andrews, 
1997).
There are also reports of toxicity associated with the use of 
cocaine adulterated with other substances, most 
commonly levamisole and phenacetin. Acute adverse 
effects of levamisole include nausea, diarrhoea and 
dizziness; prolonged exposure may cause fever, insomnia, 
headache and convulsions (Brunt et al., 2009). Chronic 
use of levamisole in cocaine has been reported to be 
associated with weakened immune system, white matter 
disease, inflammation of blood vessels and other 
amphetamine-like adverse consequences related to the 
metabolite aminorex (Brunt et al., 2017b). Phenacetin has 
been documented to have carcinogenic, neurotoxic and 
nephritic adverse effects, as well as causing hallucinatory 
and cardiac side effects (Solomini et. al, 2017).
Cocaine may cause significant acute toxicity, which can 
manifest as neuropsychiatric effects and 
sympathomimetic/stimulant effects. Common effects 
include agitation, anxiety, restlessness, insomnia, paranoia 
and auditory hallucinations, as well as chest pain, 
increased heart rate and raised blood pressure. Severe 
acute toxicity may be characterised by hyperthermia, acute 
renal failure and seizures (Pasic et al., 2017). Cocaine has 
a strong reinforcing action, causing a rapid psychological 
dependence, an effect even more pronounced in those 
who smoke crack cocaine. Mental health risks associated 
with cocaine include depressed mood and, in the long 
term, depressive symptoms.
Crack cocaine use has been associated with diverse health 
outcomes, and its use is associated with a higher risk of 
sexually transmitted infections (with HIV and hepatitis 
C virus, among others). Harmful associations have been 
found between crack cocaine use and several major health 
outcomes, including substantial evidence for infectious 
diseases and moderate evidence for neonatal harm and 
violence (Butler, 2017). Recently, cocaine use has been 
reported to have played a facilitating role in an HIV 
outbreak among people who inject drugs in Luxembourg.
l  Cocaine hospital emergency presentations
There are limited systematically collected data on acute 
drug toxicity in Europe. A review of the latest national 
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reports submitted by European countries to the EMCDDA 
shows that seven out of ten reporting such data observed 
an increase in the number of cocaine-related emergencies 
in their most recent data, compared with the previous year.
Complementary information about acute health harms 
related to cocaine use comes from reports from a ‘sentinel’ 
network of emergency settings (Euro-DEN Plus), which 
collects systematic data on drug-related presentations to 
emergency departments. The network is composed of 32 
sentinel centres in 20 European countries. During the 
period 2014-2017, there were 4 460 presentations for 
powder cocaine use-related acute toxicity (19 % of all 
presentations related to drug use) and 565 crack cocaine 
use-related presentations (2 % of the total). Powder 
cocaine was involved in one third or more of the 
presentations in nine of the thirty-two Euro-DEN centres, 
which were primarily located in countries in the south and 
west of Europe.
Of those who presented with powder cocaine-related 
toxicity, 76 % were male, and the mean age was 32 years 
for males and 30 years for females. Alcohol co-ingestion 
was recorded in 57 % of the presentations. The mean 
number of drugs used in the presentations involving 
cocaine was 1.8. Around half of the presentations (46 %) 
involved cocaine alone; 48 % related to polydrug use 
involving cocaine, with either one or two additional drugs.
The most common clinical features were tachycardia 
(39 %), anxiety (32 %), agitation/aggression (29 %), chest 
pain (19 %) and palpitations (18 %). Some form of 
treatment was required for 59 %, primarily sedation, 
indicated for one third of the patients (33 %) (Figure 7). 
Sixteen patients died; these were adults aged 19-49 years, 
and in a majority of cases (10 deaths), cocaine had been 
taken with other substances, including heroin, other 
opioids, benzodiazepines and amphetamines. In terms of 
change over time, there was a small increase in the 
proportion of presentations involving powder cocaine 
between 2014 (17 %) and 2017 (21 %).
A comparison of the powder cocaine-related and crack 
cocaine-related cases shows that crack cocaine users were 
older, with a mean age of 37.6 years for males and 35 years 
for females, were less likely to have used cocaine alone (33 %) 
and were more likely to have used heroin (40 %, compared 
with 12 % of those presenting with powder cocaine-related 
toxicity). Crack cocaine presentations were distributed evenly 
throughout the week, whereas powder cocaine presentations 
were more frequent on Saturdays and Sundays.
l  Cocaine-related deaths
Increases in cocaine-related deaths have gained media 
attention recently in the United Kingdom, France and other 
European countries. The most recent EMCDDA data show 
that there were an estimated 1 220 cocaine-related deaths 
in 2016, or one in seven of the drug-related deaths 
estimated to have occurred in that year in the 28 EU 
Member States, Norway and Turkey (EMCDDA, 2018b). 
FIGURE 7
Clinical features among powder cocaine-related and crack-related cases in 2014-2017, in Euro-DEN centres
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Acute cocaine-related deaths are underestimated, as 
some fatalities, in particular deaths due to cardiac 
infarction and stroke, may not all be recognised as related 
to cocaine use. In terms of the available data on post-
mortem toxicology, there were 371 deaths in which the 
presence of cocaine was reported in the United Kingdom, 
253 in Spain, 120 in France, 71 in Germany, 38 in Italy and 
32 in Austria. These are probably underestimates, as full 
toxicology information was not available for all cases. It 
should be noted that cocaine-related deaths are rarely 
caused by cocaine alone, and polydrug intoxication is the 
norm, with cocaine commonly identified along with other 
substances such as heroin, other opioids, amphetamines, 
benzodiazepines and alcohol.
Although the numbers may be underestimations, 
a preliminary analysis of the time trends reported up to 
June 2018 suggests an increase in most countries with 
available data. Of 19 countries (17 EU countries plus 
Norway and Turkey), 12 report an increase in the number 
of cocaine-related deaths, 5 report a stable situation and 2 
report a decrease. Noticeable increases are reported, for 
example, in France, from 57 to 120 cases between 2014 
and 2016; in England and Wales, from 247 to 371 cases 
during the same period; and in Austria, Germany and 
Turkey (Figures 8 and 9). The trend in Turkey occurred in 
the context of a large increase in drug-related deaths 
reported overall and requires further investigation.
In several countries in the east and south-east of Europe, 
such as Bulgaria, Cyprus, Latvia, Hungary and Malta, the 
overall number of drug-related deaths is very small and, 
consequently, trend analysis of cocaine-related deaths is 
difficult. There are some signs of an increasing trend, 
however, for example in Slovenia, where 18 cocaine-
related deaths were reported in 2017, compared with 2 to 
5 cases reported annually in recent years.
Long-term cocaine use increases the mortality risk among 
cocaine users compared with their peers of the same age 
and gender. A recent Spanish longitudinal study showed 
that, compared with those in the general population, 
mortality was four times higher (standardised mortality 
ratio (SMR) = 4.1, 95 % CI = 3.5-4.8) among cocaine users 
and more than 10 times higher (SMR = 11.6, 95 % 
CI = 10.5-12.8), among those using both cocaine and 
opioids (Colell et al., 2018).
FIGURE 8
Trends in the number of cocaine-related deaths in 
selected EU countries (2012-2016)
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FIGURE 9
Trends in the number of cocaine-related deaths in 
selected EU countries and Turkey (2014-2016)
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l  Health responses to cocaine and crack cocaine use
In response to an increase in cocaine-related treatment 
demand, some countries have developed targeted 
programmes and interventions for cocaine users seeking 
help. Extending opening hours specifically for working 
individuals with powder cocaine problems, as in Austria, is 
one of these measures. Very recently, a specific 
programme using a combination of a community 
reinforcement approach and contingency management, 
and targeting specifically people with cocaine problems, 
has been developed in Belgium. However, overall, targeted 
programmes for cocaine users remain limited in Europe.
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Psychosocial interventions (e.g. cognitive behavioural 
therapy (CBT), motivational interviewing and brief 
interventions), contingency management, management of 
psychiatric disorders and symptomatic pharmacological 
treatment are the most commonly applied interventions 
when treating users seeking support for cocaine or crack 
dependence in Europe. This information was corroborated 
by the responses to an EMCDDA survey of over 100 
European treatment practitioners on current practices and 
shortcomings in responding to powder cocaine-related 
and crack cocaine-related problems in Europe (Figure 10). 
Concerns raised by the practitioners were an immediate 
need to improve access to existing drug treatment services 
for young cocaine users and polydrug users using cocaine; 
improve cooperation between drug services and mental 
health services; encourage closer coordination with 
emergency departments; and develop more targeted 
cocaine-related harm reduction responses. The importance 
of cocaine-related training opportunities and guidelines for 
professionals was also highlighted, especially in 
addressing moderate and severe cocaine and crack 
dependence.
Very few developments have been observed in the area of 
cocaine-related treatment during the past decade. 
Research to assess the effectiveness of stimulant 
medications such as modafinil and buproprion as cocaine 
substitutes is still ongoing. As in opioid substitution 
therapy, these stimulant medications with less abuse 
potential than the illicit drug are intended to reduce 
craving and withdrawal and thereby promote abstinence. 
Research into a cocaine vaccine is also still ongoing. This 
vaccine works by inducing the production of cocaine 
antibodies, which bind to cocaine molecules in the 
bloodstream and prevent them from passing through the 
blood-brain barrier. Other experimental methods, such as 
transcranial magnetic stimulation, computer-assisted CBT, 
acupuncture and the use of cannabis as a harm reduction 
measure, have also been explored; however, no evidence 
of their effectiveness has yet been documented (EMCDDA, 
2018a).
Instead of or in addition to using public services, cocaine 
users may seek help in private luxury clinics. However, the 
high cost makes this option exclusive and affordable to 
FIGURE 10
Tag cloud of cocaine and crack treatment-related keywords from a survey of 108 practitioners
NB: Created using The Cloud Generator (https://www.jasondavies.com/wordcloud/).
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only a small proportion of users. The main treatment 
approaches seem to be similar to those provided by public 
services, while some clinics offer alternative methods with 
limited scientific evidence for their effectiveness in the 
area of drug addiction. These providers generally offer 
individualised programmes with multi-professional teams 
in which at least one staff member is assigned exclusively 
to one client. A non-exhaustive web-based search 
indicates that luxury clinics advertising treatment to 
cocaine users are mainly located in western Europe (e.g. 
France, Spain, Switzerland and the United Kingdom).
Harm reduction interventions primarily target high-risk 
cocaine-related behaviours, such as unsafe injection and 
crack cocaine smoking practices, and promote safer sexual 
behaviours. Examples of these interventions include 
smoking and injecting drug consumption rooms in 
Denmark, Germany, France, Luxembourg and the 
Netherlands. These settings offer an environment where 
cocaine can be used under the supervision of specially 
trained staff. In low-threshold agencies, for example in 
Ireland, France and Portugal, crack cocaine kits including 
pipes and filters are provided to users to encourage safer 
smoking practices (e.g. Pfau and Cadet-Taïrou, 2018); in 
Belgium, bicarbonate of soda is included in crack cocaine 
kits to encourage users who transform powder cocaine 
into crack to use baking soda instead of the commonly 
used and more harmful ammonia. Drug checking services 
also play a role in the reduction of cocaine-related harms 
in some EU countries. These can be important in informing 
users about risks associated with high-purity or 
adulterated cocaine and how to reduce such risks.
l Discussion
The European drug market appears to be experiencing 
a surge in the availability of high-purity cocaine. As 
a consequence, the stimulant of choice for many drug 
users, which in recent times used to be of moderate purity 
and sold at varying prices, has now become an affordable 
commodity with high purity levels.
l  Supply pressure: more players, competition and innovation in the cocaine trade
The main drivers behind this surge in cocaine supply 
include a sharp increase in coca production in source 
countries since 2014. Closer to home, an increasing 
number of European and non-European organised crime 
groups are now directly involved in the cocaine trade 
between source countries and national markets in the 
various Member States. New trafficking routes are 
emerging or gaining importance, for example routes 
through overseas territories close to source countries (e.g. 
Guyana) and traditional cocaine-smuggling methods are 
evolving, with innovative concealment methods, 
intimidation and bribery. We are also observing the 
multiplication and diffusion of entry points into Europe. 
Traditional trafficking hubs in Spain, the Netherlands and 
Italy are being complemented by ports and airports in 
Belgium, France and Germany, and this may represent only 
the tip of the iceberg, as other routes and trafficking 
modes, such as private aviation, may simply go 
undetected. As a result, large quantities of cocaine appear 
to be entering Europe at a regular pace, and law 
enforcement and customs agents are facing challenges in 
containing the flow.
A reorganisation of the cocaine supply chain is also visible 
at mid-level and retail level, with the emergence of 
fragmented, looser and more horizontal structures. Novel 
technologies such as encrypted communication 
applications, the darknet, social media and 
cryptocurrencies are playing an important role in enabling 
smaller groups and individual ‘entrepreneurs’ to engage, 
with a perception of less risk, in cocaine dealing. 
Entrepreneurship in a competitive cocaine market is 
evidenced by innovative distribution strategies such as 
cocaine-exclusive call centres. These new methods, 
reflecting an ‘Uberisation’ of the cocaine trade, are clear 
signs of a competitive market in which sellers have to 
promote additional services beyond the product itself, 
such as fast delivery anywhere at any time. The trade in 
cocaine between vendors and buyers traditionally operated 
mostly within small circles and was concealed from the 
public. We are now seeing a qualitative change in the 
nature of cocaine dealing, whereby social media is used to 
promote cocaine and other illicit drugs relatively openly, 
with the aim of reaching as many potential consumers as 
possible.
Smaller organised crime groups and darknet vendors, as 
opposed to large structured criminal syndicates, are 
increasingly operating in local markets at national level and 
are competing for various consumer bases. As 
a consequence, cocaine has become a modern-day 
commodity, and the levels of purity and perceived quality 
of the product are now a major selling point. The 
opportunity for retail vendors to sell discounted high-purity 
cocaine in the Member States appears to have been 
facilitated by a number of interlinked factors. First, an 
influx of cocaine into Europe, with reports of surpluses, 
may have resulted in high-purity wholesale cocaine being 
sold off to mid-level and retail vendors at lower prices. 
Second, fewer intermediaries being involved in the supply 
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chain reduces opportunities to further adulterate the initial 
product. Third, increased purity and a reduction in 
psychoactive adulterants in cocaine products have been 
linked to regulatory changes that have limited 
opportunities to procure traditional cutting agents such as 
levamisole and benzocaine.
l Diffusion to new and emerging markets
Cocaine has always played an important role in the 
European stimulant market, primarily in western European 
countries. However, there are signs that cocaine is 
expanding into new markets in eastern Europe and 
beyond. Cocaine use was rare in these markets, where 
amphetamines have a long tradition of being the stimulant 
of choice among most user groups. Recent data show, 
however, an increase in seizures, purity levels and reports 
that cocaine is entering the range of drugs on offer by 
street dealers. It is suggested that this may be linked to 
increased economic growth observed in the eastern EU 
region in recent years. Another factor may be a saturation 
of the cocaine market in some western European 
countries, requiring organised crime groups to seek new 
markets within and beyond the EU’s borders to the east. It 
is also possible that Europe has become a transit region 
for new cocaine markets in western Asia.
Expansion into new markets has also been observed 
within national territories, for example in France, where 
organised crime groups are expanding their operations 
from major cities to smaller, regional cities. This diffusion 
of cocaine markets may be due to oversaturation and 
a high degree of competition in traditional localised 
markets. One potential consequence is a so-called 
glocalisation of cocaine-related consumption patterns. For 
example, crack used to be a particularly localised 
phenomenon observed among small pockets of highly 
marginalised users in a few European cities such as 
Frankfurt and Paris. However, crack cocaine use is now 
appearing across various user groups in other cities such 
as Copenhagen, Dublin, Lisbon and Luxembourg.
l Consumer dynamics: a complex picture
From a consumer perspective, there is some evidence of 
interchangeability between cocaine and other stimulant 
drugs, depending on the availability and purity of cocaine 
on the market. The recent increase in availability of 
high-purity cocaine may have shifted the preference of 
certain subgroups of stimulant users, for example in 
nightlife settings, from what users consider ‘second-class’ 
stimulants, such as amphetamine, mephedrone and other 
cathinones, towards now-higher purity cocaine. Recent 
significant reductions in the availability of new 
psychoactive substances, including cathinones, on the 
European market may have contributed to this 
phenomenon.
Several additional factors appear to be associated with an 
increased preference for cocaine. There are reports that 
use of cocaine is becoming normalised in certain youth 
populations, coupled with increased disposable income 
among these groups following the economic recovery in 
most European countries. Most experts agree that those 
participating in certain youth cultures appear to display 
a lower risk perception towards cocaine. This normalisation 
of use can be partly attributed to cocaine being 
increasingly glamourised in popular culture, for example in 
recent popular TV series such as Narcos and Gomorrah. 
Such normalisation and misunderstanding of the harms 
caused by cocaine-related products may have negative 
repercussions. For example, reports from France indicate 
that an erroneous distinction is being made in some 
subgroups between base cocaine (‘freebase’) and crack, 
with the potential for users to underestimate the risks 
associated with this more dangerous form of cocaine use.
Finally, this study also raises the question of the extent to 
which supply factors are currently shaping consumers’ 
behaviour. Data available from the EMCDDA 
epidemiological indicators on drug use do not yet reflect 
the evidence of increasing supply of cocaine into the 
European market. On the other hand, targeted surveys and 
data collection in nightlife settings, in drug consumption 
rooms and in wastewater studies appear to point to 
a steady rise in cocaine use in recent years. What is less 
clear is if these data are identifying actual increases in the 
number of users, that a similar number of users are using 
more frequently or using higher purity products, or 
a combination of these factors. Importantly, further 
research is needed to confirm whether the current supply 
of cocaine is attracting new, drug-naive users on a wider 
scale at population level or whether it is primarily tapping 
into an existing consumer base formed of various user 
groups in nightlife settings and high-risk drug users.
l  Harms and responses: implications for policy, practice and monitoring
Various harms have been linked to recent increases in the 
availability and use of cocaine. At a societal level, media 
reports have highlighted an increase in extreme violence 
among small organised crime groups competing for local 
cocaine markets. Intimidation of indebted consumers, 
bribery of officials and exploitation of women as drug 
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couriers are only some of the worrying indications of the 
violence associated with the increasing importance of the 
cocaine trade in Europe.
At consumer level, the available data from hospital 
emergency presentations reveal that it is primarily a young 
population of cocaine users that appears in emergency 
rooms at weekends, with similar temporal spikes in 
cocaine use at weekends to those observed in wastewater 
data. With increasing purity levels of cocaine and co-use of 
alcohol among young recreational cocaine users, more 
attention should be paid and efforts devoted to the 
development of tailored harm reduction interventions for 
this group. In addition, the development of treatment 
services catering to the needs of younger users developing 
cocaine-related problems is required. Such services could 
attract this subgroup of young users at an early stage in 
the development of problem use. Examples of such newly 
developed services for cocaine users have been reported 
in Belgium but still remain rare. New technologies such as 
e-health and m-health applications for cocaine users may 
play an important role in expanding the reach of current 
treatment and harm reduction services in Europe.
Data on trends in the number of cocaine-related deaths in 
Europe raise some concerns. The number of deaths 
involving cocaine, mostly in association with alcohol and 
opioids, has dramatically increased in several countries in 
recent years. In some countries, such as France and the 
United Kingdom, these increases mirror those observed in 
the number of opioid-related deaths during the same 
period. This may indicate that the rise in deaths involving 
cocaine may largely be driven by the ageing cohort of 
vulnerable high-risk opioid users still primarily observed in 
western Europe. Available evidence from the literature, 
confirmed by experts in this study, shows that cocaine — 
powder cocaine or crack — is used by high-risk opioid 
users, in or out of treatment, as a replacement or add-on to 
heroin or to opioid substitution treatment. This has 
important implications for practitioners in terms of 
managing the problem co-use of cocaine among these 
groups. Experts consulted and practitioners surveyed in 
this study were adamant regarding the priorities in this 
area. First, investment is required in efforts to build the 
capacity of professionals through skills development and 
training in the treatment of stimulant dependence, with 
a focus on diagnosis and management of psychiatric 
comorbidities. Second, more investment is needed at 
European level in research into the development of 
effective pharmacological treatments. Currently, most 
research in this field is carried out in the United States, 
which may have different research priorities given the 
current opioid crisis there. In addition, greater investment 
in harm reduction and treatment services may be required, 
considering the possible expansion of crack cocaine use in 
Europe. The range of harms associated with crack cocaine 
use goes well beyond the direct effects of the product, with 
crime, sexual abuse and financial debts commonly 
reported among this group. Among users of crack cocaine, 
women, members of ethnic minority groups and new 
migrants are particularly at risk of harms related to their 
drug use. Tailored services catering to the specific needs 
of these populations, such as culturally relevant services or 
women-only services, should be a priority where crack 
cocaine use is observed.
Finally, this study also revealed important implications for 
monitoring. Most standard epidemiological drug indicators 
appeared to be ill suited to detecting the current 
emergence of cocaine use in specific groups and in the 
overall population. Some indicators are currently failing to 
show the required sensitivity and reliability in evidencing 
the geographical and temporal developments in particular 
patterns of use, such as that of crack cocaine use. More 
efforts and investment are required to fine-tune existing 
instruments. Increasingly, new data collection methods, 
such as wastewater analysis, collecting data from 
emergency presentations and collecting data from harm 
reduction services, such as drug consumption rooms, 
low-threshold agencies and drug checking services, may 
be useful. The results from these new data collection 
methods complement data obtained from existing routine 
data collection instruments and can provide, as observed 
in this study, an important insight into the latest drug 
trends and dynamics of specific drugs, such as cocaine, 
across different user groups, different settings and national 
drug markets in countries where these methods can be 
applied.
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